Acasti Pharma Inc ACST

Healthcare

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.

NDAQ:ACST - Post by User

Acasti Pharma Inc > ATM

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Aug 22, 2020 11:47am

110 Views

Post# 31441635

RE:RE:RE:RE:ATM

Call your broker and ask for the control no. Use it to vote on line.

Zamboni99 wrote: How do. I vote? Based on what I've been listening to these past few years, I'd gladly vote Jan out of there. But I haven't received any documents/instructions for my ACST shares like I always do with my other equities. Also Francine, is there another individual on the ballot that you recommend?
Thanks

<< Previous

Bullboard Posts

Next >>

This gambling tech stock might be the safest bet you’ll make this year